Evidence map›Paper›PMID 11485932›Full record

ArticleThe American journal of pathology2001

Renal cholesterol accumulation: a durable response after acute and subacute renal insults.

R A Zager, T Andoh, W M Bennett

Open access · bronzeAbstract read
In one paragraph

Article in The American journal of pathology, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Article
  3. The Cross-Link between Ferroptosis and Kidney Diseases.Oxidative medicine and cellular longevity · 2021
    Review
  4. Article
  5. Article
  6. Article
  7. Hypoxia: The Force that Drives Chronic Kidney Disease.Clinical medicine & research · 2016
    Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. HMG-CoA reductase activation and urinary pellet cholesterol elevations in acute kidney injury.Clinical journal of the American Society of Nephrology : CJASN · 2011
    Article
  14. Antibodies reactive to non-HLA antigens in transplant glomerulopathy.Journal of the American Society of Nephrology : JASN · 2011
    Article
  15. Review
  16. Article
  17. Article
  18. Isolation of renal progenitor cells from adult human kidney.The American journal of pathology · 2005
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

R A ZagerDepartment of Medicine, Fred Hutchinson Cancer Center, University of Washington, 1100 Fairview Ave. N, Rm. D2-190, Seattle, WA 98109, USA. dzager@fhcrc.org
T Andoh
W M Bennett
Legacy Good Samaritan Medical Center · USFred Hutch Cancer Center · US

Funding

Acute Renal Failure: Mechanisms and Adaptive ResponsesR37DK038432 · NIDDK · FRED HUTCHINSON CANCER RESEARCH CENTER · PI ZAGER, RICHARD A. · 2002 to 2011
$3.9M
SEPSIS INDUCED ACUTE RENAL FAILURER01DK038432 · NIDDK · UNIVERSITY OF WASHINGTON · PI ZAGER, RICHARD A. · 1988 to 2015
$2.1M
NIDDK NIH HHS DK38432NIDDK NIH HHS R01 DK038432NIDDK NIH HHS R01 DK 37652NIDDK NIH HHS R37 DK038432PHS HHS R01 54200
6 · The paper itself

Abstract

unlabelledProximal tubular cholesterol levels rise within 18 hours of diverse forms of acute renal tubular injury (eg, myoglobinuria, ischemia/reperfusion, urinary tract obstruction). These increments serve to protect against further bouts of tubular attack (so-called "acquired cytoresistance"). Whether these cholesterol increments are merely transitory, or persist into the maintenance phase of acute renal failure (ARF), has not been previously defined. Furthermore, whether subacute/insidious tubular injury [eg, cyclosporine A (CSA), tacrolimus toxicity], nontubular injury (eg, acute glomerulonephritis), or physiological stress (eg, mild dehydration) impact renal cholesterol homeostasis have not been addressed. This study sought to resolve these issues. Male CD-1 mice were subjected to glycerol-induced ARF. Renal cortical-free cholesterol (FC) and cholesterol ester (CE) levels were determined 3, 5, 7, or 14 days later, and the values contrasted to prevailing blood-urea nitrogen concentrations. The impact of 40 minutes of unilateral renal ischemia plus reflow (3 to 6 days) on mouse cortical FC/CE content was also assessed. Additionally, FC/CE levels were measured in rat renal cortex either 10 days after CSA or tacrolimus therapy, or 48 hours after induction of nephrotoxic serum nephritis. Finally, the impact of overnight dehydration on mouse renal cortical/medullary FC/CE profiles was determined. Compared to sham-treated animals, glycerol, CSA, tacrolimus, ischemia-reperfusion, and nephrotoxic serum each induced dramatic CE +/- FC elevations, rising as much as 10x control values. In the glycerol model, striking correlations (r </= 0.99) between FC/CE and blood-urea nitrogen levels were observed. The FC/CE increases were specific to damaged kidney (glycerol did not raise hepatic FC/CE; unilateral renal ischemia did not alter contralateral renal FC/CE levels). Overnight dehydration raised renal CE levels, most notably in the medulla.

conclusionsFC/CE accumulation is a hallmark of the maintenance phase of ischemic and nephrotoxic ARF, and can reflect its severity. That cholesterol accumulation can result from glomerular injury and dehydration suggests that it is a generic renal stress response, with potential relevance extending beyond just the phenomenon of acquired cytoresistance.

Indexed as

Acute Kidney InjuryAnimalsBlood Urea NitrogenCholesterolCholesterol EstersCyclosporineDehydrationGlomerulonephritisGlycerolIschemiaKidneyKidney CortexKidney MedullaKidney TubulesMaleMiceCholesterolCholesterol EstersCyclosporineGlycerolTacrolimus

Identifiers

PMID11485932
PMCPMC1850565
OpenAlexW27378885

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.